Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03431948
Title Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer (C4 MOSART)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago

Advanced Solid Tumor


Nivolumab + Urelumab

Cabiralizumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.